NR3C2 and cancer: In a proof-of-principle clinical study, middle-aged individuals subjected to a low methionine diet (about 2.92 mg kg−1 day−1, represented an 83% reduction in methionine intake) showed altered circulating metabolism, which further demonstrated therapeutic effects of MR on cancer [89].